Carbamazepine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Carbamazepine and local guidelines before prescribing.

Anticonvulsant (sodium-channel blocker)

Mechanism

Blocks voltage-gated sodium channels; stabilises neuronal membranes.

Uses

Focal and generalised tonic-clonic epilepsy, trigeminal neuralgia, bipolar disorder.

Dosing

3 more dose entries from the chapters
  • Carbamazepine Start 100 mg once or twice daily | Trigeminal neuralgia; low sodium, rash, enzyme induction.
    Neurology: Headache and Facial Pain
  • Carbamazepine 100 mg once or twice daily, increasing slowly.
    Neurology: Headache and Facial Pain
  • Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
    Obstetrics

Side effects

Dizziness, diplopia, ataxia, hyponatraemia, rash, leucopenia; serious skin reactions (HLA-B*15:02), hepatotoxicity.

Interactions

Potent enzyme inducer lowering warfarin, DOACs, COC pill and many drugs; levels raised by macrolides and some azoles.

Contraindications and cautions

AV block, porphyria, HLA-B*1502 (Asian ancestry) for SJS/TEN, bone marrow depression

Monitoring

Sodium, FBC, LFT, levels

Pregnancy and breastfeeding

Teratogenic (neural tube defects); specialist advice

Renal and hepatic impairment

Reduce dose in liver impairment

Overdose and reversal

Charcoal; supportive and ECG

Special advice

Check sodium, LFT and FBC; contraception advice; avoid in pregnancy where possible (neural tube defects); do not stop abruptly.

More from the textbook: uses, cautions and other points
Where it is discussed in the book